Breast cancer detection tool from Parascript wins FDA nod

09/6/2013 | American City Business Journals

The FDA has granted Parascript approval for its AccuDetect software, designed to aid in early breast cancer diagnosis. In an analysis, the technology helped improve the detection of tumors missed in initial exams by 18.8% and achieved a 14.2% reduction in the number of follow-up tests from false positives, the company said.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD